NIASPAN is a prescription niacin agent indicated to RAISE HDL-C, REGRESS atherosclerosis and REDUCE recurrent non-fatal MI*
NIASPAN coated tablets deliver the same proven benefits
NIASPAN 1000-mg coated tablet has been reformulated and a new film coating
applied to all dosing strengths (500 mg,
750 mg, 1000 mg).
- 1000-mg coated tablet has been reformulated
- Dry-mixed, directly compressed, and then film-coated
- Bioequivalent of two 500-mg coated tablets
- 1 vs 2 tablets may enhance convenience
- May make titration to 1000 mg easier
- In a pharmacokinetic study of healthy volunteers, the extent of absorption for the 1000-mg coated tablet was the same as original 1000-mg coated tablet, while the rate of absorption was slower1
How to prescribe NIASPAN Extended-Release Tablets
Titrate NIASPAN Extended-Release Tablets for optimal response
NIASPAN is a prescription niacin agent indicated to RAISE HDL-C, REGRESS atherosclerosis and REDUCE recurrent non-fatal MI*
* In patients with a history of coronary artery disease and hypercholesterolemia, niacin, in combination with a bile acid binding resin, is indicated to slow progression or promote regression of atherosclerotic disease. In patients with a history of myocardial infarction and hypercholesterolemia, niacin is indicated to reduce the risk of recurrent nonfatal myocardial infarction.
Next: Safety and Tolerability
References
1. American Heart Association. Cholesterol-lowering drugs. Dallas: TX. Available online at: http://www.americanheart.org/presenter.jhtml?identifier=163
